Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost–consequence analysis

BACKGROUND: In patients with advanced gastroesophageal cancer, the phase iii Randomized ECF for Advanced and Locally Advanced Esophagogastric Cancer 2 (real-2) trial demonstrated equivalent clinical efficacy when capecitabine (x) was substituted for 5-fluorouracil (5fu) in the epirubicin–cisplatin–5...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Horgan, A.M., Knox, J.J., Liu, G., Sahi, C., Bradbury, P.A., Leighl, N.B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Multimed Inc. 2011
Konular:
Medical Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070713/
https://ncbi.nlm.nih.gov/pubmed/21505591
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller